The Medical Products industry faces moderate growth prospects with resilient healthcare demand offset by tariff pressures and manufacturing costs. ICU Medical shows strong momentum in infusion systems with improving earnings, Neogen benefits from commercial execution improvements in food and animal safety, while Trulieve Cannabis expects growth acceleration from new markets like Georgia and Texas despite Florida seasonal softness.
TRLV
Trulieve Cannabis Corp. · NYSE
$10.42USD
↓ $0.50 (4.58%)
Last close · Oct 23, 4:00 PM ET
Sign up free to see this.
Mkt Cap
$2B
Volume
106.6K
52W High
$12.93
52W Low
$7.82
PE Ratio
—
Avg Vol
2.2M
As of 10/23/26
Div Yield
0.72%
Beta
—
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about TRLV?
Latest news
News ›Headlines link to the publisher. Not investment advice.
Board · 0 threads
Open board ›No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Posts 24h
0
Replies 24h
0
Watchers
0
Board · $TRLV · 0 threads
Sign in to post on $TRLV
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.